Direxion Daily S&P Biotech Bull 3x Shares Rating $178.62 0.00 (0.00%) As of 06/12/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Direxion Daily S&P Biotech Bull 3x Shares Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.LABU Aggregate RatingModerate Buy 2.74Holdings in LABU have an aggregate rating of Moderate Buy based on 260 analyst ratings issued in the past year covering 16 companies (16.6% of the portfolio).LABU Aggregate Price Target$178.62High Prediction$178.62Average Prediction$178.62Low Prediction$178.62Holdings in LABU have an aggregate price target of $178.62 and a range of $178.62 to $178.62 covering 16 companies (16.6% of the portfolio).LABU Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold1 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily S&P Biotech Bull 3x Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 16 LABU Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.25%TWSTTwist Bioscience$76.172.0836 of 5 stars2.78$61.38 -19.4%9Positive News1.24%TVTXTravere Therapeutics$52.041.4411 of 5 stars2.69$50.17 -3.6%13Analyst ForecastGap Down1.24%RVMDRevolution Medicines$153.871.7998 of 5 stars3.00$123.72 -19.6%22Positive NewsGap Down1.24%ALKSAlkermes$44.282.3272 of 5 stars2.76$46.13 4.2%171.15%TGTXTG Therapeutics$49.522.3093 of 5 stars2.71$52.50 6.0%7Gap Down1.03%ARWRArrowhead Pharmaceuticals$74.522.7874 of 5 stars2.75$87.80 17.8%12Positive News1.02%NBIXNeurocrine Biosciences$159.763.8519 of 5 stars2.87$187.52 17.4%231.00%BEAMBeam Therapeutics$29.033.1028 of 5 stars2.71$46.83 61.3%14Positive News1.00%EXELExelixis$53.133.08 of 5 stars2.39$47.35 -10.9%23Positive News0.96%KRYSKrystal Biotech$317.972.7803 of 5 stars2.83$324.11 1.9%12Positive NewsGap Up0.96%APGEApogee Therapeutics$88.333.2757 of 5 stars2.74$114.56 29.7%19Insider Trade0.91%MDGLMadrigal Pharmaceuticals$480.773.7064 of 5 stars2.78$687.93 43.1%18Positive News0.91%VCYTVeracyte$47.332.3519 of 5 stars2.56$47.57 0.5%9Positive News0.90%NTRANatera$212.074.074 of 5 stars2.81$256.53 21.0%21Positive NewsGap Up0.90%CRSPCRISPR Therapeutics$49.803.5246 of 5 stars2.58$67.78 36.1%19Analyst Forecast0.90%CYTKCytokinetics$70.153.7153 of 5 stars2.86$99.30 41.6%22 This page (NYSEARCA:LABU) was last updated on 6/15/2026 by MarketBeat.com Staff. From Our PartnersLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredIs SpaceX really worth 1.78 Trillion?With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...InvestPub | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredSpaceX is chump change compared to Elon’s $20T ‘iPhone’Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...StocksToTrade | SponsoredThe roadshow starts Monday. This stock isn't ready.The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...Behind the Markets | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredThis is the worst news for stocks in 50 yearsGoldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...TradeSmith | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bull 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bull 3x Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
